Percentage (Number) of doses relative to each discrete dose scheme which are optimal doses based on the optimal toxicity interval (θ ± 0.10).</p
<p>Distribution of intermediate toxicity for each pathway interval of all compounds listed in metacy...
<p>Normalization is performed with respect to the doses derived from the treatment plans and plotted...
<p>Percentage of reduction of total drug concentration of combinatorial treatment versus single drug...
Percentage (Number) of doses relative to each discrete dose scheme which are optimal doses based on ...
Percentage of trials with the estimated MTD inside the toxicity optimal interval and average percent...
Percentage of trials with the estimated MTD inside the optimal MTD interval and average percentage o...
<p>In column (A), the color at each point represents the value of <i>c</i><sub>1</sub> that correspo...
<p>Percentage of doses allocated to each priority group by vaccine type for two proportionally fair ...
• Fundamental assumption in Phase I designs is the monotonicity of the dose-toxicity curve • Dose-li...
<p>Note: In each scenario, the first row of number in parentheses corresponds to the dose selection ...
<p>Percentile plot of the percent of ordered doses that were administered for each patient on the pa...
<p>In column (A), the color at each point represents the value of <i>c</i><sub>1</sub> that correspo...
<p>(A) We show the probability of resistance, <i>P</i>, over the range of treatment schedules specif...
Vaccination is a key tool to reduce global disease burden. Vaccine dose can affect vaccine efficacy ...
Percentage volumes receiving at least X% of prescription dose (VX%) of organs at risk.</p
<p>Distribution of intermediate toxicity for each pathway interval of all compounds listed in metacy...
<p>Normalization is performed with respect to the doses derived from the treatment plans and plotted...
<p>Percentage of reduction of total drug concentration of combinatorial treatment versus single drug...
Percentage (Number) of doses relative to each discrete dose scheme which are optimal doses based on ...
Percentage of trials with the estimated MTD inside the toxicity optimal interval and average percent...
Percentage of trials with the estimated MTD inside the optimal MTD interval and average percentage o...
<p>In column (A), the color at each point represents the value of <i>c</i><sub>1</sub> that correspo...
<p>Percentage of doses allocated to each priority group by vaccine type for two proportionally fair ...
• Fundamental assumption in Phase I designs is the monotonicity of the dose-toxicity curve • Dose-li...
<p>Note: In each scenario, the first row of number in parentheses corresponds to the dose selection ...
<p>Percentile plot of the percent of ordered doses that were administered for each patient on the pa...
<p>In column (A), the color at each point represents the value of <i>c</i><sub>1</sub> that correspo...
<p>(A) We show the probability of resistance, <i>P</i>, over the range of treatment schedules specif...
Vaccination is a key tool to reduce global disease burden. Vaccine dose can affect vaccine efficacy ...
Percentage volumes receiving at least X% of prescription dose (VX%) of organs at risk.</p
<p>Distribution of intermediate toxicity for each pathway interval of all compounds listed in metacy...
<p>Normalization is performed with respect to the doses derived from the treatment plans and plotted...
<p>Percentage of reduction of total drug concentration of combinatorial treatment versus single drug...
DOI
Add to ORKG